Observational Study of Immune Responses in Prostate Cancer Patients Following Stereotactic Body Radiotherapy (SBRT)

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Induction of anti-prostate cancer immunity

Outcome Time Frame:

Before, during and after Stereotactic Body Radiotherapy (SBRT)

Safety Issue:

No

Principal Investigator

Sean S Park, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Mayo Clinic

Authority:

United States: Institutional Review Board

Study ID:

12-008383

NCT ID:

NCT01777802

Start Date:

January 2013

Completion Date:

June 2015

Related Keywords:

• Oligometastatic Prostate Cancer
• Prostatic Neoplasms

Name	Location
Mayo Clinic in Rochester	Rochester, Minnesota  55905